Cargando…
Psoriasis and Atherosclerosis—Skin, Joints, and Cardiovascular Story of Two Plaques in Relation to the Treatment with Biologics
It is known that both psoriasis (PSO) limited to the skin and psoriatic arthritis (PSA) increase the risk of cardiovascular complications and atherosclerosis progression by inducing systemic inflammatory response. In recent decades, the introduction of biological medications directed initially again...
Autores principales: | Wierzbowska-Drabik, Karina, Lesiak, Aleksandra, Skibińska, Małgorzata, Niedźwiedź, Michał, Kasprzak, Jarosław D., Narbutt, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508744/ https://www.ncbi.nlm.nih.gov/pubmed/34638740 http://dx.doi.org/10.3390/ijms221910402 |
Ejemplares similares
-
Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability
por: Narbutt, Joanna, et al.
Publicado: (2023) -
Off-label medications in the treatment of hospitalized children with atopic dermatitis
por: Niedźwiedź, Michał, et al.
Publicado: (2022) -
Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2021) -
Micronutrient deficiency with skin and systemic symptoms: a case report of acrodermatitis enteropathica
por: Rajczak, Maria, et al.
Publicado: (2023) -
COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
por: Ceryn, Justyna, et al.
Publicado: (2021)